Skip to main content
Biofrontera AG logo

Biofrontera AG — Investor Relations & Filings

Ticker · B8F ISIN · DE000A4BGGM7 LEI · 391200D6GFSVFGFQTL13 F Manufacturing
Open in API
Filings indexed 120 across all filing types
Latest filing 2014-03-31 Annual Report
Country DE Germany
Listing F B8F

About Biofrontera AG

https://www.biofrontera.com/en/

Biofrontera AG is a biopharmaceutical company that specializes in dermatology. The company develops and markets innovative products for the treatment, care, and protection of the skin. Its core expertise is in photodynamic therapy (PDT), a non-invasive treatment for various skin conditions. Biofrontera's products are primarily focused on treating forms of non-melanoma skin cancer, such as actinic keratosis, field cancerization, and basal cell carcinoma. The portfolio includes both dermatological drugs and medical cosmetics.

Recent filings

Filing Released Lang Actions
Datum:31.03.2014
Annual Report Classification · 100% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) and 'Lagebericht' (Management Report) for Biofrontera AG for the fiscal year 2013. It contains detailed information on corporate structure, strategy, product pipelines, and market positioning. As it represents the comprehensive annual reporting of the company's activities and financial performance, it is classified as an Annual Report (10-K). FY 2013
2014-03-31 German
Datum:10.03.2014
Report Publication Announcement Classification · 100% confidence The document is a short announcement (1062 characters) titled 'Hinweis auf Jahresfinanzbericht' (Notice of Annual Financial Report). It explicitly states that the company is announcing the publication of its annual financial reports and provides a link to where they can be accessed online. Per the 'Menu vs Meal' rule, this is an announcement of a report rather than the report itself, making it a Report Publication Announcement (RPA).
2014-03-10 German
Datum:12.11.2013
Board/Management Information Classification · 100% confidence The document is a 'Bericht des Aufsichtsrats' (Supervisory Board Report) for Biofrontera AG for the fiscal year 2011. It details the board's activities, committee work, and the approval of the annual and consolidated financial statements. In German corporate reporting, this report is a mandatory component of the Annual Report (Geschäftsbericht). Since it is a core section of the annual reporting package rather than a standalone audit report or a simple announcement, it is classified as an Annual Report (10-K).
2013-11-12 German
Hinweis auf Zwischenmitteilung der Geschäftsführung vom 01.01.2013 bis zum 30.09.2013
Report Publication Announcement Classification · 100% confidence The document is a short announcement (approx. 1050 characters) that serves as a notification regarding the publication of a financial report (Zwischenmitteilung). It provides a link to the website where the actual report can be found and specifies the publication date. According to the 'Menu vs Meal' rule, since this is an announcement of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2013-10-16 German
Konzernabschluss zum Geschäftsjahr vom 01.01.2012 bis zum 31.12.2012
Annual Report Classification · 100% confidence The document is a comprehensive annual report for Biofrontera AG for the fiscal year 2012. It includes a 'Konzernabschluss' (consolidated financial statements), a 'Zusammengefasster Lage- und Konzernlagebericht' (combined management report), and detailed sections on business strategy, revenue, product development, and market performance. As it covers the full fiscal year and contains substantive financial and operational analysis, it is classified as an Annual Report (10-K). FY 2012
2013-09-23 German
Datum:02.08.2013
Annual Report Classification · 100% confidence The document is a comprehensive 'Jahresfinanzbericht 2012' (Annual Financial Report 2012) for Biofrontera AG, covering the fiscal year 2012. It includes a 'Zusammengefasster Lagebericht' (Management Report), detailed business strategy, revenue analysis, product descriptions, and financial context. As it is a full annual report containing substantive financial data and management analysis, it is classified as an Annual Report (10-K). FY 2012
2013-08-02 German

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.